English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51186995    Online Users :  573
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"ann lii cheng"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 516-525 of 690  (69 Page(s) Totally)
<< < 47 48 49 50 51 52 53 54 55 56 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-08-31T06:29:17Z Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma Kelley R.K.; Mollon P.; Blanc J.-F.; Daniele B.; Yau T.; ANN-LII CHENG; Valcheva V.; Marteau F.; Guerra I.; Abou-Alfa G.K.
臺大學術典藏 2021-08-31T06:29:17Z Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma Finn R.S.; Qin S.; Ikeda M.; Galle P.R.; Ducreux M.; Kim T.-Y.; Kudo M.; Breder V.; Merle P.; Kaseb A.O.; Li D.; Verret W.; Xu D.-Z.; Hernandez S.; Liu J.; Huang C.; Mulla S.; Wang Y.; Lim H.Y.; Zhu A.X.; ANN-LII CHENG; IMbrave150 Investigators
臺大學術典藏 2021-08-31T06:29:17Z Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival Chen T.W.-W.; Jan I.-S.; Chang D.-Y.; Lin C.-H.; Chen I.-C.; Chen H.-M.; ANN-LII CHENG; Lu Y.-S.
臺大學術典藏 2021-08-31T06:29:17Z IMbrave 050: A Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation Hack S.P.; Spahn J.; Chen M.; ANN-LII CHENG; Kaseb A.; Kudo M.; Lee H.C.; Yopp A.; Chow P.; Qin S.
臺大學術典藏 2021-08-31T06:29:17Z A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements Kudo M.; Han K.-H.; Ye S.-L.; Zhou J.; Huang Y.-H.; Lin S.-M.; Wang C.-K.; Ikeda M.; Chan S.L.; Choo S.P.; Miyayama S.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:29:16Z Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial Kelley R.K.; Ryoo B.-Y.; Merle P.; Park J.-W.; Bolondi L.; Chan S.L.; Lim H.Y.; Baron A.D.; Parnis F.; Knox J.; Cattan S.; Yau T.; Lougheed J.C.; Milwee S.; El-Khoueiry A.B.; ANN-LII CHENG; Meyer T.; Abou-Alfa G.K.
臺大學術典藏 2021-08-31T06:29:16Z Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design Kelley R.K.; W Oliver J.; Hazra S.; Benzaghou F.; Yau T.; ANN-LII CHENG; Rimassa L.
臺大學術典藏 2021-08-31T06:29:16Z A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; Yeh K.-H.; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:29:15Z A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women Tsai M.-S.; Chang S.-H.; Kuo W.-H.; Kuo C.-H.; Li S.-Y.; Wang M.-Y.; Chang D.-Y.; Lu Y.-S.; Huang C.-S.; ANN-LII CHENG; Lin C.-H.; Chen P.-C.
臺大學術典藏 2021-08-31T06:29:15Z A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy Lin Z.-Z.; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; ANN-LII CHENG; Lee R.-C.; Chao Y.; Hsu C.

Showing items 516-525 of 690  (69 Page(s) Totally)
<< < 47 48 49 50 51 52 53 54 55 56 > >>
View [10|25|50] records per page